APA (7th ed.) Citation

Takeuchi, S., Hirata, K., Magota, K., Watanabe, S., Moku, R., Shiiya, A., . . . Dosaka-Akita, H. (2023). Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: A prospective, multicentre, non-randomised study. EJNMMI Research, 13(1), 1. https://doi.org/10.1186/s13550-023-01019-9

Chicago Style (17th ed.) Citation

Takeuchi, Satoshi, et al. "Early Prediction of Treatment Outcome for Lenvatinib Using 18F-FDG PET/CT in Patients with Unresectable or Advanced Thyroid Carcinoma Refractory to Radioiodine Treatment: A Prospective, Multicentre, Non-randomised Study." EJNMMI Research 13, no. 1 (2023): 1. https://doi.org/10.1186/s13550-023-01019-9.

MLA (9th ed.) Citation

Takeuchi, Satoshi, et al. "Early Prediction of Treatment Outcome for Lenvatinib Using 18F-FDG PET/CT in Patients with Unresectable or Advanced Thyroid Carcinoma Refractory to Radioiodine Treatment: A Prospective, Multicentre, Non-randomised Study." EJNMMI Research, vol. 13, no. 1, 2023, p. 1, https://doi.org/10.1186/s13550-023-01019-9.